Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-145,000
Closed -$274K 59
2025
Q4
$274K Buy
145,000
+117,500
+427% +$217K 0.21% 73
2025
Q3
$54.2K Hold
27,500
0.05% 91
2025
Q2
$54.5K Hold
27,500
0.07% 55
2025
Q1
$42.4K Hold
27,500
0.18% 25
2024
Q4
$53.6K Buy
+27,500
New +$65.2K 0.16% 24

Other funds holding ADAG

Fifth Lane Capital's ADAG Position: Q1 2026 in Review

Fifth Lane Capital sold out of Adagene (ADAG) in Q1 2026, closing a stake of 145,000 shares — an estimated $274K sold.

Fifth Lane Capital first reported a position in ADAG in Q4 2024 and held it in 5 quarters. The position peaked at $274K in Q4 2025. 25 funds tracked by Wall St. Rank hold ADAG as of Q1 2026.

  • Fifth Lane Capital reported no remaining Adagene position as of Q1 2026 after selling out during the quarter.
  • Fifth Lane Capital sold 145,000 Adagene shares in Q1 2026, an estimated $274K.
  • Fifth Lane Capital first reported a position in Adagene in Q4 2024 and held it in 5 quarters.
  • Fifth Lane Capital's Adagene position peaked at $274K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Adagene as of Q1 2026.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.